Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -68.1133.8294.6045.00-24.35

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is -68.11 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00
Mar2020-24.35

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45
Positive
Mar2020 -24.35 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹150.2 Cr -5% -9.2% -26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,017.0 Cr -0.2% -0.5% 10.7% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 4% 4.8% 50.5% Stock Analytics
CIPLA ₹122,451.0 Cr 0.4% 3.1% 1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,620.0 Cr 5.9% 9.1% 23% Stock Analytics
DR REDDYS LABORATORIES ₹106,572.0 Cr -4.8% 2.2% 2.9% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-5%

-9.2%

-26.9%

SENSEX

2%

2.8%

6.4%


You may also like the below Video Courses